BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6296008)

  • 1. A randomized clinical trial of ceftizoxime and cefamandole in the treatment of serious lower respiratory tract infections.
    Rodriguez J; Vazquez GJ; Bermudez RH; Luina A; Ronda CH
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():209-13. PubMed ID: 6296008
    [No Abstract]   [Full Text] [Related]  

  • 2. Ceftizoxime compared with cefamandole for treatment of soft tissue infections.
    Mills J; Slutkin G; Klein D; Schecter W
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():273-9. PubMed ID: 6296020
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative study of ceftizoxime and cefamandole in the treatment of bronchopulmonary infections.
    LeFrock JL; Molavi A; Lentnek AL; Rolston KV; Chandrasekar PH; Smith BR; Kannangara W; Schell RF; Oaks SS; Carr BB
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():215-21. PubMed ID: 6296009
    [No Abstract]   [Full Text] [Related]  

  • 4. A double-blind evaluation of ceftizoxime versus cefamandole therapy for urinary tract infections.
    Penn RL
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():241-5. PubMed ID: 6296014
    [No Abstract]   [Full Text] [Related]  

  • 5. Ceftizoxime and cefamandole in adult patients with acute respiratory failure.
    Lyons RW; Brock SM; Lahiri B
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():227-8. PubMed ID: 6296011
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative trial of ceftizoxime versus cefamandole in the treatment of acute urinary tract infections.
    Lea AS; Sudan AW; Gould PL; Gentry LO
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():261-3. PubMed ID: 6296018
    [No Abstract]   [Full Text] [Related]  

  • 7. Ceftizoxime therapy of infections in hospitalized patients and comparison with cefamandole for urinary tract infections.
    Cohen E; Mogabgab WJ
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():253-60. PubMed ID: 6296017
    [No Abstract]   [Full Text] [Related]  

  • 8. Ceftizoxime in the treatment of urinary tract infections.
    Plimpton HW; Crawford ED
    J Urol; 1982 Dec; 128(6):1231-2. PubMed ID: 6296465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of cefotiam and cefamandole in respiratory tract infections.
    Beumer HM; Olislagers WP; Kahn M; van Hamersveld JD
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):105-8. PubMed ID: 3886564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summary of comparative clinical studies of ceftizoxime and cefamandole, cefazolin and tobramycin.
    Duma RJ
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():303-9. PubMed ID: 6296025
    [No Abstract]   [Full Text] [Related]  

  • 11. Single-blind controlled study of ceftizoxime and cefamandole in the treatment of community-acquired pneumonia.
    Grieco MM; Lange M; Daniels JA; Den M; Amaram N; Kornfeld H
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():223-5. PubMed ID: 6296010
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomized controlled study comparing ceftizoxime, cefamandole, and cefoxitin in obstetric and gynaecological surgery: a preliminary report.
    Gordon SF; Russell J
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():289-92. PubMed ID: 6296022
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized clinical trial comparing the safety and efficacy of cefonicid and cefamandole in the treatment of patients with respiratory tract infections caused by susceptible pathogens.
    Azanza JR; Honorato J; Rubio A; Cuena R
    Chemioterapia; 1987 Jun; 6(2 Suppl):449-51. PubMed ID: 3334597
    [No Abstract]   [Full Text] [Related]  

  • 14. Cefoperazone versus cefamandole in the treatment of acute bacterial lower respiratory tract infections.
    File TM; Tan JS; Gardner WG; Baird I
    J Antimicrob Chemother; 1983 Jan; 11(1):75-82. PubMed ID: 6219089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftizoxime treatment of cutaneous and subcutaneous tissue infections.
    Parish LC; Parks DB; Layne PP; Uri JV
    Clin Ther; 1984; 6(5):613-9. PubMed ID: 6090019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefamandole in the treatment of lower respiratory tract infections.
    Clarke CW; Hannant CA; May CS; Rawal BD
    J Antimicrob Chemother; 1980 Nov; 6(6):723-31. PubMed ID: 7440465
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative study of cefuzonam (CZON) with cefmenoxime in chronic respiratory tract infections by the double-blind method].
    Soejima R; Matsushima T; Niki Y; Kawane H; Kawanishi M; Watanabe M; Hino J; Nakagawa Y; Umeki S; Sumi M
    Kansenshogaku Zasshi; 1986 Aug; 60(8):865-84. PubMed ID: 3098871
    [No Abstract]   [Full Text] [Related]  

  • 18. [Double-blind comparison of cefamandole and cefazolin in the therapy of respiratory tract infections (author's transl)].
    Jpn J Antibiot; 1980 Mar; 33(3):375-409. PubMed ID: 6995640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefamandole in the treatment of purulent respiratory infections. Studies of 3 and 4 g daily in 121 patients.
    Pines A; Jabbar MA; Khorasani MH; Raafat H; Sharma JC
    Chemotherapy; 1981; 27(1):68-72. PubMed ID: 7215006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized comparative trial with ceftizoxime and cefotaxime in urinary tract infections.
    Tripi M; Pavone-Macaluso M; Giammanco A; Carella G
    Int Urol Nephrol; 1985; 17(3):195-202. PubMed ID: 3910604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.